Ovarian germ cell tumours
Exam relevance: in 3 of more than 150 board exam reports · rank 125
- Specialty
- Gynaecology · Ovary & adnexa
- Images
- Histology & cytology 3
- Exam relevance
- 3 of more than 150 reports · rank 125
- In the app
- 2 flashcards · GynFuchs
- Last updated
- 10/2026 · Dr. Pascal Bafteh
Contents
Images (3)
Histology & cytology
Histology & cytology
Histology & cytologyDefinition
- Ovarian germ cell tumours arise from primitive germ cells; about 95% are benign mature cystic teratomas and only about 5% are malignant.
- Yolk sac tumour is a malignant primitive germ cell tumour that histologically resembles the mesenchyme of the primitive yolk sac.
Classification
Germ cell and sex cord-stromal tumours
- Most common germ cell tumour: The most common germ cell tumour is the mature teratoma, i.e., the dermoid cyst.
- Malignant germ cell tumours: Malignant germ cell tumours are dysgerminoma, yolk sac tumour, immature teratoma, and choriocarcinoma — typically in young women.
- Sex cord-stromal tumours: Sex cord-stromal tumours include granulosa cell tumour, theca cell tumour, fibroma, and Sertoli-Leydig cell tumour.
- Granulosa cell tumour: The granulosa cell tumour is clinically conspicuous due to oestrogen production with bleeding disorders, endometrial hyperplasia, or precocious puberty.
- Sertoli-Leydig cell tumour: The Sertoli-Leydig cell tumour causes virilisation due to androgen production.
Classification and epidemiology
- Among malignant types, in order of frequency, come dysgerminoma, immature teratoma, yolk sac tumour and mixed germ cell tumour; embryonal carcinoma, choriocarcinoma and malignant struma ovarii are rarer.
- Dysgerminoma accounts for about one third of malignant germ cell tumours; 80–85% of patients are under 30, and it is the most common ovarian tumour diagnosed in pregnancy and the puerperium.
- Malignant germ cell tumours are mostly unilateral, but pure dysgerminoma is bilateral in 10–15%.
Aetiopathogenesis
Aetiology
- Germ cell tumours can arise in dysgenetic gonads, for example in Turner or Swyer syndrome; with a Y chromosome a gonadoblastoma may develop, which undergoes malignant transformation in more than 40%.
Clinical features
- Occasionally the tumours produce hCG and cause signs of precocious puberty.
Histology
- Dysgerminomas are well encapsulated, firm and solid; tumour cells are surrounded by connective tissue containing lymphocytes, and diffuse strong nuclear OCT4 staining is characteristic.
- Schiller-Duval bodies are diagnostic of yolk sac tumour but are found in only about one third of cases.
Diagnosis
Tumour markers
- CA 19-9: The marker CA 19-9 is characteristically elevated in mucinous ovarian tumours and in pancreatic and biliary tract carcinomas.
- CEA: Carcinoembryonic antigen (CEA) is elevated primarily in gastrointestinal carcinomas, suggesting a metastasis in the case of an adnexal finding.
- Granulosa cell tumour: If a granulosa cell tumour is suspected, one measures inhibin B and anti-Müllerian hormone.
- Diagnosis relies on history, examination, ultrasound and the serum markers LDH, AFP and hCG: LDH is typical of dysgerminoma, AFP of yolk sac tumour and hCG of choriocarcinoma.
Treatment principles
- As mostly young women are affected, fertility-sparing surgery with removal of the affected ovary and staging is the standard.
- Malignant germ cell tumours are highly chemosensitive; depending on histology and stage, chemotherapy follows, usually with very good prospects of cure.
- Follow-up relies on tumour markers and imaging; treatment is coordinated with the tumour board.
Specific treatment regimens with drugs and doses are covered in the GynFuchs app.
Keep learning in the app
Further reading (selection)
Cross-references
Keep learning
Keep learning with flashcards, exam questions and spot diagnoses in the GynFuchs app – free, in your browser or as an app.
Related pages: Krukenberg tumour · Meigs syndrome · Ovarian cancer
Note: Learning content from the GynFuchs app (flashcards, exam questions, image cases) for medical education – not a treatment recommendation and no substitute for diagnosis or treatment decisions in individual cases. Treatment and management are deliberately not covered on this page.